Skip to search formSkip to main contentSkip to account menu

molgramostim

Known as: recombinant human GM-CSF 
National Institutes of Health

Related topics

Related topics

13 relations

Broader (4)

Antineoplastic AgentsGranulocyte-Macrophage Colony-Stimulating FactorRecombinant Granulocyte-Macrophage Colony-Stimulating FactorsRecombinant Proteins
Cytokine Receptor ActivationHematopoiesis InductionHematopoietic stem cellsMonocytes

Narrower (1)

Gramal

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Locally applied molgramostim improves wound healing at colonic anastomoses in rats after ligation of the common bile duct.
BACKGROUND Several systemic factors, including jaundice, long-term corticosteroid therapy, diabetes and malnutrition, increase… 
2004
2004
Topical Effectiveness of Molgramostim (GM-CSF) in Sickle Cell Leg Ulcers
Background: Leg ulcers are a frequently neglected, severe complication of sickle cell disease (SCD), responsible for significant… 
2003
2003
Granulocyte‐macrophage colony stimulating factor prior to chemotherapy for advanced epithelial ovarian cancer
2003
2003
Safety and Efficacy of Molgramostim as an Adjunctive Therapy in Critically Ill Patients with Severe Sepsis
The aim of this uncontrolled, prospective, clinical study was to investigate the efficacy and safety of molgramostim… 
2000
2000
Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
Myelokathexis is a very rare form of chronic hereditary neutropenia resulting from impaired neutrophil releasing mechanism in the… 
1998
1998
Randomized study of filgrastim versus molgramostim after peripheral stem cell transplant in breast cancer.
BACKGROUND AND OBJECTIVE The aim of this study was to compare the efficacy and toxicity of Filgrastrim (granulocyte colony… 
1997
1997
Long-term safety of GM-CSF (molgramostim) administration after allogeneic bone marrow transplantation for hematologic malignancies: five-year follow-up of a double-blind randomized placebo-controlled…
In a double-blind, randomized study performed between 1988 and 1990, 40 patients undergoing allogeneic BMT from HLA-identical… 
1997
1997
Granulocyte-stimulating factor filgrastim and molgramostim induced recurring encephalopathy and focal status epilepticus
12. Liu GT, Crenner AM, Logigian EL, Chamess ME, Samuels MA (1992) Midbrain syndromes of Benedikt, Claude and Nothnagel: setting… 
1995
1995
Unexpected hepatotoxicity after priming and treatment with molgramostim (rhGM‐CSF) in acute myeloid leukemia during induction chemotherapy
The effect of supplementing induction chemotherapy with recombinant human granulocyte‐macrophage colony‐stimulating factor (rhGM… 
Review
1993
Review
1993
Cost considerations in therapy with myeloid growth factors.
Costs of biologic response modifiers, specifically myeloid growth factors, are discussed relative to cost offsets they may… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)